Previous studies have reported that ovarian cancer cells increase FST production in response to TGF-β stimulation (84), and FST expression has been shown to coincide with the activation of the signaling cascades downstream of EGF signaling in leukemia cells (85), however, signaling events driving FST in HNSCC cells remain unknown. The gene discussed is FST; the disease is head and neck squamous cell carcinoma.